Results 291 to 300 of about 1,048,085 (335)

The Silent Carrier of Beta Thalassemia

New England Journal of Medicine, 1969
Abstract A family of Albanian descent had an unusual form of beta thalassemia. The father of two children with mild thalassemia major had normal red-cell morphology and normal levels of hemoglobins A2 and F, whereas the mother had elevated hemoglobin A2.
openaire   +2 more sources

Platyspondyly in treated beta-thalassemia

European Journal of Radiology, 1994
Flattening of the vertebral bodies with a platyspondyly appearance is described in 14 patients selected for evaluation of short stature from 106 patients affected by thalassemia major, who received an intensive transfusion regimen combined with continuous chelation therapy.
C, Orzincolo, G, Castaldi, P N, Scutellari   +2 more
openaire   +2 more sources

[Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study].

Klinische Padiatrie, 2000
At present, about 300 patients with thalassemia major are living in Germany. Starting in 1991, a multicenter study in Germany has concentrated on identifying all patients suffering from thalassemia as well as on establishing a uniform therapy protocol including follow-up diagnostic procedures.
H, Cario, K, Stahnke, E, Kohne
openaire   +1 more source

Beta Thalassemia

Hematology/Oncology Clinics of North America, 2019
Eugene Khandros, Janet L. Kwiatkowski
openaire   +1 more source

Non-fullerene acceptors with branched side chains and improved molecular packing to exceed 18% efficiency in organic solar cells

Nature Energy, 2021
Chao Li, Huotian Zhang, Lei Zhu
exaly  

Beta‐Thalassemias

2004
Antonio Cao, Renzo Galanello
openaire   +2 more sources

SARS-CoV-2 variant biology: immune escape, transmission and fitness

Nature Reviews Microbiology, 2023
Alessandro Maria Carabelli, William T Harvey, Joseph Hughes   +2 more
exaly  

Cardiac involvement in beta-thalassemia major and beta-thalassemia intermedia.

Hemoglobin, 2005
The forms and severity of cardiac complications were investigated in patients with asymptomatic thalassemia intermedia and thalassemia major by M-mode, bi-dimensional echocardiography (ECHO) and echo-Doppler. Twenty-eight patients of both sexes with beta-thalassemia intermedia (beta-TI), mean age 23.2 +/- 6.3 years, untransfused or minimally transfused,
Mara, Ferrara, Sofia M R, Matarese, Barbara, Borrelli, Angelo, Perrotta, Gelsomina, Simeone, Natalizia, Greco, Diana, Iarussi, Luigi, Esposito   +7 more
openaire   +1 more source

Cardiac complications and iron overload in beta thalassemia major patients—a systematic review and meta-analysis

Annals of Hematology, 2019
F. Koohi, T. Kazemi, E. Miri-Moghaddam
semanticscholar   +1 more source

In Brief: Casgevy for Beta Thalassemia

The Medical Letter on Drugs and Therapeutics
Exagamglogene autotemcel (Casgevy – Vertex), a cell-based gene therapy recently approved for treatment of sickle cell disease1, has now been approved by the FDA for treatment of patients ≥12 years old with transfusion-dependent beta thalassemia.
openaire   +2 more sources